More Articles
News Headlines
Custom Search
CTIC

CTIC

Last Trade: 1.14
Trade Time: 4:00pm ET
Change: Up 0.16 (16.33%

strong day strong close

 Cell Therapeutics, Inc., a biopharmaceutical company, develops, acquires, and commercializes oncology products for cancer treatment. Its development portfolio includes Pixantrone, a phase III trial product, for non-Hodgkin’s lymphoma; Brostallicin, which is in first-line Phase II study for the treatment of sarcoma; and OPAXIO, a chemotherapeutic agent for the potential treatment of non-small cell lung, ovarian, and other cancers.


DiggDigg   | RedditReddit   | Add to Mixx!MixxDeldel.icio.usStumble Stumble it!Bookmark and Share Share it

 
Name  
Comment
Verification Code code

Comments submitted from other visitors

More posts, Page # :